Find and Pitch Jounalists, Get Your Story Covered

Tags: ULA Vulcan rocket Cape Canaveral digiday+Agency Culture

	Profile	Recent Articles on Subject
1	Adam Feuerstein STAT News Reporter at STATnews. Dog lover. Polk Award winner. Boston, Massachusetts biotech reporting	Lilly’s earnings surprise, investors mull the election, & a spooky ghost story - 13 days ago STAT+: Pharmalittle: We’re watching more positive data for Ozempic, a Lilly factory expansion, and more - 6 months ago
2	Elaine Chen STAT News Reporter at STATnews. Formerly at Business Insider. Chicago, Illinois journalism	Lilly’s earnings surprise, investors mull the election, & a spooky ghost story - 13 days ago It’s happy hour (for now) for Alnylam - 4 months ago As GLP-1 sales surge, insulin users fear Novo Nordisk and Eli Lilly will move on without them - 4 months ago STAT+: Eli Lilly to acquire Morphic for $3.2 billion - 4 months ago
3	Allison DeAngelis STAT News Reporter at STAT. Formerly Insider, BBJ. biopharmastartupsventure capital	Lilly’s earnings surprise, investors mull the election, & a spooky ghost story - 13 days ago STAT+: Eli Lilly reports tirzepatide MASH success during Q4 earnings - 9 months ago
4	Eric Volkman Motley Fool Investing guidance to make the world smarter, happier, richer. InvestingFinancial Guidance	Why Lilium Stock Plummeted by 21% Today - 27 days ago Why Eli Lilly Stock Topped the Market Today - 7 months ago Why Eli Lilly Stock Was Feeling Sickly on Wednesday - 9 months ago Why Eli Lilly Stock Flopped While the Market Popped Today - 12 months ago Why Elanco Animal Health Stock Was Pure Catnip to Investors This Week - about 1 year ago
5	Adam Spatacco Motley Fool Community for top investors. Investingcommunity	This is Huge News For Eli Lilly Investors - 28 days ago Eli Lilly Just Made Zepbound Even More Appealing. Here's What Smart Investors Need to Know. - 2 months ago Did Eli Lilly Just Get a Leg Up on Novo Nordisk? - 4 months ago This Is Massive News for Eli Lilly Investors - 5 months ago Move Over, Mounjaro. Eli Lilly Has Another Blockbuster in the Making - 6 months ago Prediction: Eli Lilly and Novo Nordisk Stock Could Just be Getting Started. Here's Why - 8 months ago
6	Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA medicalinnovation	Eli Lilly Plans $4.5B Medicine Foundry to Foster Innovations in Drug Manufacturing - about 1 month ago Eli Lilly Moves Closer to Bringing Diabetes Patients a Once-Weekly Insulin Alternative - 2 months ago Eli Lilly Drug Reduces Risk of Diabetes Onset, Building Case for Broader Use of the Therapy - 3 months ago Eli Lilly Shows Appetite for Oral Immunology Drugs, Swallowing Morphic in $3.2B Deal - 4 months ago Eli Lilly Alzheimer’s Drug Lands FDA Approval, Introducing Competition to Eisai’s Leqembi - 4 months ago Eli Lilly Puts $1B on the Line to Expand its Cancer Radiopharmaceuticals Prospects - 5 months ago Eli Lilly Pumps $5.3B More Into Site for Making Metabolic Meds Zepbound & Mounjaro - 6 months ago
7	Meghana Keshavan STAT News Biotech nerd and writer @statnews. biotechwriting	Eli Lilly releases new data on weekly insulin - 2 months ago Lilly has more positive data on its weekly insulin - 2 months ago Eli Lilly’s anti-vanity ad campaign for Oscars - 8 months ago Novartis is building a new radioligand plant in China - 12 months ago
8	Amy Baxter Pharma Voice Scientist, inventor, former pediatrician. Atlanta, Georgia pain relieftechnologyinnovation	Lilly lays down $1B to be ‘first in biology’ with obesity gene therapies - 2 months ago Pfizer and Lilly are elbowing into the direct-to-consumer market. Will it work? - 6 months ago
9	Andrew Joseph STAT News Reporter at STAT. Covers health, medicine in Europe. London, England health reportingmedicine	STAT+: Pharmalittle: We’re watching positive Zepbound cardiovascular data, a move to take 23andMe private, and more - 3 months ago STAT+: In surprise move, FDA calls for advisory committee on Lilly’s Alzheimer’s drug - 8 months ago STAT+: In drug development, large pharma companies’ staying power provides them an edge, Lilly’s chief medical officer says - about 1 year ago
10	Meagan Parrish Pharma Voice Senior editor @industrydive. Pharma world follower. Wisconsin, USA pharmaceuticalsjournalismparenting	Amylyx’s CEOs on their ALS setback and quest to revamp the pipeline - 4 months ago Could Novo, Lilly become first trillion-dollar healthcare companies? - 10 months ago

Journalists covering eli lilly and company